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Abstract
Aims/hypothesis Mitochondria frequently change their
shapes by fusion and fission and these morphological
dynamics play important roles in mitochondrial function and
development as well as programmed cell death. The goal of
thisstudyistoinvestigatewhether:(1)mitochondriainmouse
coronary endothelial cells (MCECs) isolated from diabetic
mice exhibit increased fragmentation; and (2) chronic
treatment with a superoxide anion (O2
−) scavenger has a
beneficial effect on mitochondrial fragmentation in MCECs.
Methods MCECs were freshly isolated and lysed for protein
measurement, or cultured to determine mitochondrial mor-
phologyandO2
− production. For the ex vivo hyperglycaemia
experiments, human coronary endothelial cells were used.
Results Elongated mitochondrial tubules were observed in
MCECs isolated from control mice, whereas mitochondria
in MCECs from diabetic mice exhibited augmented
fragmentation. The level of optic atrophy 1 (OPA1) protein,
which leads to mitochondrial fusion, was significantly
decreased, while dynamin-related protein 1 (DRP1), which
leads to mitochondrial fission, was significantly increased
in MCECs from diabetic mice. Diabetic MCECs exhibited
significantly higher O2
− concentrations in cytosol and
mitochondria than control MCECs. Administration of the
O2
− scavenger TEMPOL to diabetic mice for 4 weeks led to
a significant decrease in mitochondrial fragmentation
without altering the levels of OPA1 and DRP1 proteins in
MCECs. High-glucose treatment for 24 h significantly
induced mitochondrial fragmentation, which was restored
by TEMPOL treatment. In addition, excess O2
− production,
either in cytosol or in mitochondria, significantly increased
mitochondrial fragmentation.
Conclusions/interpretation These data suggest that lower-
ing the O2
− concentration can restore the morphological
change in mitochondria and may help improve mitochon-
drial function in diabetic MCECs.
Keywords DRP1.Endothelium.Fission.Fusion.
Mitochondrial dynamics.O2
−.OPA1.Type 1 diabetes
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HCECs Human coronary endothelial cells
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Diabetic cardiomyopathy, a prominent cardiovascular com-
plication, has been recognised as a microvascular disease
and a primary cause of morbidity and mortality in diabetic
patients. The pathogenesis of diabetic cardiomyopathy
involves coronary endothelial cell (EC) dysfunction, fibro-
sis, cardiac myocyte dysfunction and cardiac myocyte
necrosis. We recently reported that coronary ECs from
diabetic mice are dysfunctional in regulation of vascular
tone and angiogenesis [1]. In addition, we and other
investigators [2, 3] demonstrated that EC apoptosis is
significantly increased in the diabetic heart; however, the
molecular mechanism is not clear.
Recent work has highlighted the importance of mito-
chondrial dynamics in cells and animal physiology. Be-
cause mitochondria constantly fuse and divide, an
imbalance of these two processes dramatically alters overall
mitochondrial morphology [4]. It is now clear that
mitochondrial dynamics play important roles in mitochon-
drial functions, including development, apoptosis and
functional complementation of mitochondrial DNA
(mtDNA) mutations by content mixing [5–11].
There are at least five proteins which regulate mitochon-
drial fusion and fission: optic atrophy 1 (OPA1), mitofusins 1
and 2 (MFN1, MFN2), dynamin-related protein 1 (DRP1)
and fission 1 (FIS1). MFN1, MFN2 and OPA1 are essential
for mitochondrial fusion and FIS1 and DRP1 are required
for mitochondrial fission in mammals [7, 12]. MFN1 and
MFN2 reside on the outer membrane with the N-terminal
GTPase, where it is predicted to have a coil protruding into
the cytosol [13], while OPA1 is an intermembrane-space
protein [14]. These proteins work together to promote
mitochondrial fusion [15]. DRP1 exists largely in a cytosolic
pool, but a fraction localises to puncta on mitochondria [16].
FIS1 has a single transmembrane domain at the C-terminal
end such that the bulk of the molecule is exposed to the
cytosol [17]. It has been suggested that FIS1 recruits DRP1
from the cytosol to mitochondria for the fission reaction [17,
18]. Those proteins are associated with different kinds of
disease, most of which are related to neuropathy [19–25].
Leinninger et al. previously reported that a change in the
DRP1 protein level is caused by hyperglycaemia [26]. Other
studies indicate a close relationship between MFN2 and
type 2 diabetes and obesity [27, 28].
Mitochondria are a primary source of reactive oxygen
species (ROS) during production of ATP by the complexes
of the respiratory chain. While ROS production is occurring
in mitochondria throughout life, mtDNA is more sensitive
than genomic DNA to ROS-induced damage, as it is not
protected by histones and its repair capabilities are limited
[29]. There is increasing evidence showing the involvement
of the superoxide anion (O2
−) in the pathogenesis of
diabetes-associated vascular complications [30, 31]. High-
glucose treatment of cultured endothelial cells induces
overproduction of mitochondrial O2
− [32]. In vivo studies
show overproduction of cytosolic O2
− in aortic endothelial
cells in type 1 diabetes [33–35]. There is, however, no
direct evidence demonstrating the change of mitochondrial
O2
− concentration in vivo or the relationship between O2
−
concentration and mitochondrial fission in ECs in diabetes.
In this study, we show increased mitochondrial frag-
mentation, decreased OPA1 and increased DRP1 protein
production in mouse coronary endothelial cells (MCECs)
isolated from diabetic mice. In addition, we found that
morphological changes in mitochondria that occurred as a
result of diabetes were restored by O2
− scavenger treatment
without changing OPA1 and DRP1 protein levels.
Methods
Materials M199, antibiotic reagents, dispase II, Mito
Tracker Green FM, MitoSOX Red and dihydroethidium
(DHE) were purchased from Invitrogen (Carlsbad, CA,
USA). Anti-OPA1, anti-MNF1, anti-MNF2, anti-FIS1, anti-
DRP1 and anti-actin antibodies were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). Anti-CD31
and endothelial cell growth supplement (ECGS) were
obtained from BD Biosciences (San Jose, CA, USA).
Collagenase II was purchased from Worthington Biochem-
ical (Lakewood, NJ, USA). All other chemicals were from
Sigma-Aldrich (St Louis, MO, USA).
Animal preparation All investigations conformed to the
Guide for the Care and Use of Laboratory Animals
published by the National Institutes of Health (NIH
Publication No. 85-23, Revised 1985). This study was
conducted in accordance with the guidelines established by
the Institutional Animal Care and Use Committee at the
University of California, San Diego. Male NIH Swiss mice,
6 weeks of age, were purchased from Harlan Sprague Dawley
(Indianapolis, IN, USA) and mice in the diabetic group
received a single injection of streptozotocin (160 mg/kg,
dissolved in citrate buffer, i.v.). All data were obtained from
mice 10 weeks after injection. Administration of 4-hydroxy-
2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPOL, an O2
−
scavenger) was started at 6 weeks after streptozotocin
injection and continued for 4 weeks (1 mmol/l in drinking
water). Plasma glucose levels were 8.1±1.0 mmol/l
in control mice, 40.2±4.5 mmol/l in diabetic mice and
35.6±3.5 mmol/l in TEMPOL-treated diabetic mice.
Isolation of mouse coronary vascular endothelial cells
MCECs were isolated as described previously [1]. Briefly,
dissected heart tissues were minced and incubated with
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dispase II, for 1 h at 37°C. The digested material was
filtered through sterile 40 μm nylon mesh and washed in
2% (vol./vol.) FCS–M199. Subsequently, the cells were
incubated with Dynabeads (Invitrogen) which were pre-
pared as follows: beads coated with sheep anti-rat IgG were
incubated with purified rat anti-mouse CD31 monoclonal
antibody (1 μg/ml) at 4°C overnight and then washed with
PBS containing 0.1% (wt/vol.) BSA and 2 mmol/l EDTA.
The cell suspension was incubated with beads for 1 h at
4°C and then beads attached to endothelial cells were
captured by the Dynal magnet (Invitrogen).
Quantification of mitochondrial morphology in living
cells Isolated MCECs were cultured in M199 (containing
5 mmol/l glucose) supplemented with 20% (vol./vol.) FCS,
100 μg/ml ECGS, 100 U/ml penicillin, 100 μg/ml strepto-
mycin, 50 mg/l D-valine and 16 U/ml heparin. Cells were
plated on glass chamber slides coated with 1% (wt/vol.)
gelatine. After 3 days of recovery from isolation, mitochon-
drial morphology was assessed. Cells were stained with
100 nmol/l Mito Tracker Green FM for 30 min to visualise
mitochondrial morphology and then washed three times with
media. Images were captured with a DeltaVision deconvo-
lution microscope system (Applied Precision, Issaquah, WA,
USA) located at the University of California, San Diego
Cancer Center microscope facility. Using a ×60 (numerical
aperture1.4)lens,imagesof∼50serialopticalsections,spaced
by 0.15 μm, were acquired. The data sets were deconvolved
and optical sections merged to produce three-dimensional
pictures using SoftWorx software (Applied Precision) on a
Silicon Graphics Octane workstation [36] and the volume of
individual mitochondria was measured by SoftWRx 2.50
software (www.api.com/pdfs/lifescience/AppNote-3Dmodel
ing.pdf). The morphological changes were assessed with
mitochondrial volume (μm
3) as a variable. The volume of
individual mitochondria (total mitochondria number was
500–2,000 per cell) was measured and the average individual
mitochondrial volume per cell was calculated. The average
individual mitochondrial volume from each cell was used to
calculate the mean and SEM (6–15 cells per experiment).
Cytosolic and mitochondrial O2
− measurement in ECs O2
−
was detected by using the fluorescent probe DHE (for
cytosol O2
− detection) or MitoSOX Red (for mitochondrial
O2
− detection). Cells were preloaded with 50 μmol/l DHE
or 5 μmol/l MitoSOX Red for 30 min before capturing
images. Cytosolic DHE exhibits blue fluorescence, but
once it is oxidised by O2
− to ethidium bromide (EB), it
intercalates within the cell’s DNA, staining its nucleus a
fluorescent red. The index of cytosolic O2
− concentration is
described as a ratio of EB and DHE. MitoSOX Red is cell
permeant and is rapidly and selectively targeted to the
mitochondria. Once in the mitochondria, MitoSOX Red is
oxidised by O2
− and exhibits red fluorescence. A value of
red fluorescence intensity in the mitochondria was mea-
sured and mitochondrial O2
− concentration is described as a
normalised value by fluorescence intensity in control cells.
Western blot analysis After isolation of MCECs, cells were
lysed and centrifuged at 16,000 g for 10 min at 4°C.
Supernatant fractions were used as protein samples.
Samples were separated on SDS-polyacrylamide gels and
transferred to nitrocellulose membranes. Blots were then
incubated with a primary antibody (against: OPA1, MFN1,
MFN2, FIS1 or DRP1 [1:500]; or actin [1:4,000]) followed
by incubation with a horseradish-peroxidase-conjugated
secondary antibody. The immunoblots were detected with
Western Lightning ECL Detection Reagent (Perkin Elmer
LAS, Norton, OH, USA). Band intensity was normalised to
actin controls and expressed in arbitrary units.
Determination of protein oxidation in the hearts Cell
extracts were freshly prepared from whole hearts by homo-
genisation in 500 μl lysate buffer. Protein carbonyl content
was measured according to the manufacturer’s protocol
(OxiBlot Protein Oxidation Detection Kit, Chemicon Interna-
tional, Temecula, CA, USA) [37]. Briefly, protein samples
(15 μg/lane) were derivatised with dinitrophenyl hydrazine,
fractionated by 12% SDS-PAGE and transferred to nitrocel-
lulose membranes. The derivatised proteins were sequential-
ly reacted with rabbit anti-dinitrophenyl antibody and
horseradish peroxidase-conjugated goat anti-rabbit IgG and
were visualised by chemiluminescence.
Measurement of plasma 8-iso-PGF2α level To assess
oxidant stress in the plasma, 8-iso-PGF2α level in the
plasma was measured using the Isoprostane Oxidative
Stress Assay Kit B (Enzo Life Sciences International,
Plymouth Meeting, PA, USA). The kit uses a polyclonal
antibody to 8-iso-PGF2α to bind, in a competitive manner,
the 8-iso-PGF2α in the sample or an alkaline phosphatase
molecule which has 8-iso-PGF2α covalently attached to it.
Plasma samples were collected and stored at −20°C before
use. To hydrolyse the ester bond, 25 μl of 10 mol/l NaOH
was added to 100 μl of plasma. The samples were heated at
45°C for 2 h, and 25 μl of concentrated HCl (12.1 mol/l)
was added to neutralise the samples. The samples were then
centrifuged for 5 min at 20,817 g and the clear supernatant
fraction was used in the assay. After a simultaneous
incubation at room temperature, the excess reagents were
washed away and substrate was added. After a short
incubation time the enzyme reaction was stopped and
the yellow colour generated was read on a microplate
reader at 405 nm. The intensity of the bound yellow
colour is inversely proportional to the concentration of
Diabetologia (2010) 53:1783–1794 17858-iso-PGF2α in either standards or samples. The measured
optical density was used to calculate the concentration of
8-iso-PGF2α.
Ex vivo high glucose treatment in ECs To test the effect of
high glucose ex vivo, we used human coronary artery
endothelial cells (HCECs) purchased from Cell Applica-
tions (San Diego, CA, USA). HCECs were used only for
the experiments with results shown in Figs 6, 7 and 8, but
other experiments were carried out with freshly isolated
MCECs. For high-glucose treatment (HG), 20 mmol/l glu-
cose was added to the media (the final glucose concentra-
tion was 25 mmol/l). In a control group of cells, equimolar
mannitol was added to exclude the potential effect of
changes in osmolarity (normal glucose [NG]: glucose
concentration, 5 mmol/l). After 24 h, ECs were used for
the measurement of O2
− production, mitochondrial fission,
and OPA1 protein production. In another group of cells,
TEMPOL (10 μmol/l) was added to the media 1 h before
application of high glucose.
Drp1–small hairpin (sh)RNA transfection in HCEC Down-
regulation of DRP1 in HCECs was achieved using the
Drp1 (also known as Dmn1l)–shRNA plasmid (Santa Cruz
Biotechnology) and the Amaxa Nucleofector technology
(Amaxa, Gaithersburg, MD, USA) [38]. Specific protein
knockdown was verified with western blotting. A high level
of glucose was added to the media on day 2 after the
transfection.
Statistical analysis Values are expressed as mean ± SEM.
In the case of mitochondrial volume, the volume of an
individual mitochondrion (total mitochondria number was
500–2,000 per cell) was measured and the average
individual mitochondrial volume per cell was calculated.
The average individual mitochondrial volume from each
cell was used to calculate the mean and SEM (6–15 cells
per experiment). Bonferroni tests for multiple statistical
comparisons and Student’s t test for unpaired samples were
carried out to identify significant differences. Differences
were considered to be statistically significant when p<0.05.
Results
Increased mitochondrial fragmentation in coronary ECs
isolated from diabetic mice Previous studies in human
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Fig. 1 Mouse coronary endothelial cells isolated from diabetic mice
exhibit enhanced mitochondrial fragmentation. a Representative
images showing mitochondrial morphology in primary cultured
MCECs isolated from control and diabetic mice. There are elongated
mitochondrial tubules in MCECs isolated from control mice and
MCECs from diabetic mice exhibit augmented mitochondrial frag-
mentation. Scale bar, 5 μm. b Summarised data for individual
mitochondrial volume (μm
3). For each group, n=10 cells. Data are
mean ± SEM. *p<0.05 vs control
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Fig. 2 Change in protein levels related to mitochondrial fission or
fusion in diabetic MCECs. Western blots showing OPA1, MFN1 and
MFN2 (mitochondrial fusion-related proteins), and FIS1 and DRP1
(mitochondrial fission-related proteins). Actin was used as a loading
control. OPA1 is significantly decreased in MCECs isolated from
diabetic mice compared with MCECs from control mice (control, 1.00±
0.10: diabetic, 0.52±0.03; p<0.05, n=4 samples for each group),
whereas DRP1 is significantly increased in MCECs from diabetic mice
(control, 1.03±0.29; diabetic, 2.40±0.21; p<0.05, n=4 samples for
each group)
1786 Diabetologia (2010) 53:1783–1794umbilical vein endothelial cells indicate that short-time
high-glucose treatment (15 min) induces mitochondrial
fragmentation [39]. To test the effect of hyperglycaemia in
vivo, mitochondrial morphology was compared in primary
cultured MCECs isolated from control and diabetic mice.
As shown in Fig. 1, there are elongated mitochondrial
tubules in ECs isolated from control mice, whereas ECs
from diabetic mice exhibit augmented mitochondrial
fragmentation.
Levels of mitochondrial fission- and fusion-related pro-
teins Three mitochondrial fusion-related proteins, OPA1,
MFN1 and MFN2, and two mitochondrial fission-related
proteins, FIS1 and DRP1, were tested in MCECs (Fig. 2).
OPA1 protein level was significantly decreased in MCECs
freshly isolated from diabetic mice compared with control
mice (control, 1.00±0.10; diabetic, 0.52±0.03; p<0.05, n=4
samples for each group). There was no difference in protein
levels of MNF2 between control and diabetic mice (control,
1.00±0.09; diabetic, 0.88±0.06; p=0.38, n = 2 samples for
each group), while MFN1 exhibited a non-significant trend
to increase in diabetic mice (control, 1.00±0.07; diabetic,
1.54±0.48; p=0.38, n=2 samples for each group). FIS1
protein level was unchanged in diabetic MCECs (control,
1.00±0.28; diabetic, 0.99±0.18; p=0.99, n=2 samples for
each group), whereas DRP1 protein level was significantly
higher in MCECs from diabetic than from control mice
(control, 1.03±0.29; diabetic, 2.40±0.21; p<0.05, n=4
samples for each group). These data suggest that of these
fusion- and fission-related proteins, OPA1 and DRP1 might
play the most influential role related to the mitochondrial
morphological change seen in MCECs from diabetic mice.
Increased cytosolic and mitochondrial O2
− production in
MCECs in diabetic mice It has been shown that O2
−
production is augmented in aortic ECs in diabetes [33–
35]. We tested whether MCECs from diabetic mice also
have increased O2
− production. As shown in Fig. 3a, b,
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− production. a, c Representative images showing
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−
(MitoSOX intensity normalised by control; control n=10 cells,
diabetic n=6 cells). Data are mean ± SEM. *p<0.05 vs control
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Fig. 4 Diabetes increases oxidative stress and administration of the
O2
− scavenger, TEMPOL (T), restores the level of oxidative stress.
TEMPOL was added in drinking water (1 mmol/l) for 4 weeks.
a Representative image showing the pattern of oxidised proteins.
Whole heart was used for this experiment to avoid unwelcome
oxidation during EC isolation. Arrows indicate proteins where
oxidative level was increased by diabetes and decreased by chronic
TEMPOL treatment. C, control; D, diabetic; D+T, diabetic + TEMPOL.
b Columns show the summarised data of the intensity of band 1. Actin
was used as a loading control. Data are mean ± SEM. *p<0.05 vs
control;
†p<0.05 vs diabetic. For each group, n=2 samples. c Plasma
levels of 8-iso-PGF2α, an oxidative stress marker, were increased in
diabetic mice. TEMPOL treatment significantly decreased 8-iso-
PGF2a levels. Data are mean ± SEM.
†p<0.05 vs diabetic. For each
group, n=7 samples
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− concentration was significantly higher in
MCECs isolated from diabetic mice than in MCECs from
control mice. In addition, mitochondrial O2
− production in
MCECs was significantly increased in diabetic mice
compared with control mice (Fig. 3c, d).
Augmented oxidative stress was decreased by chronic O2
−
scavenger administration in diabeticmice The O2
− scavenger
TEMPOL was administrated to diabetic mice for 4 weeks in
drinking water. As shown in Fig. 4a, several proteins in the
heart were oxidised. TEMPOL treatment markedly de-
creased the oxidised level of these proteins (Fig. 4b). The
oxidative stress marker 8-iso-PGF2α was also increased in
t h ep l a s m ao fd i a b e t i cm i c ea n dT E M P O Lt r e a t m e n t
significantly decreased the level of 8-iso-PGF2α (Fig. 4c).
These data suggest that 4 week TEMPOL treatment
beneficially decreases the oxidative stress in diabetes and
may subsequently decrease the damage induced by aug-
mented oxidative stress systemically.
Administration of TEMPOL for 4 weeks restored the
mitochondrial morphological changes in MCECs from
diabetic mice To examine whether increased O2
− produc-
tion in MCECs regulates mitochondrial fragmentation in
diabetes, TEMPOL was administrated to diabetic mice and
then MCECs were isolated from control, diabetic and
TEMPOL-treated diabetic mice. TEMPOL administration
significantly decreased mitochondrial fragmentation in
diabetic MCECs (Fig. 5a, b), but the levels of OPA1 and
DRP1 proteins were not changed by TEMPOL administra-
tion (Fig. 5c–e). In addition, levels of other fusion–fission-
related proteins were not affected by TEMPOL treatment
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Fig. 5 Administration of the O2
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4 weeks restores mitochondrial morphological changes in diabetic
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by western blot. a Representative images showing mitochondrial
morphology in primary cultured MCECs from control, diabetic and
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Fig. 6 High-glucose treatment over 24 h increases mitochondrial
fragmentation and ROS generation in cytosol and mitochondria,
whereas scavenging O2
− significantly increases mitochondrial tubular
formation without changing OPA1 and DRP1 protein levels. High
glucose (25 mmol/l) or normal glucose (5 mmol/l glucose+20 mmol/l
mannitol) was added in the culture media for 24 h. TEMPOL was
added 1 h before high glucose application. a Representative images
showing mitochondrial morphology in ECs cultured in NG, HG and
HG+TEMPOL. Bar=5 μm. b Summarised data for mitochondrial
volume (μm
3) in ECs cultured in NG (n=11 cells), HG (n=10 cells)
and HG+TEMPOL (HG+T, n=10 cells). Data are mean ± SEM. *p<
0.05 vs NG.
†p<0.05 vs HG. c Western blot showing OPA1, DRP1
and actin protein levels in ECs cultured in NG, HG and HG+T for
24 h. d, e Summarised data for (d) OPA1 and (e) DRP1 protein levels
(normalised by actin level) in ECs cultured in NG, HG and HG + T.
Data are mean ± SEM. For each group, n=2 samples. f, h Represen-
tative images showing (f) cytosolic O2
− production and (h) mitochon-
drial O2
− production in ECs cultured in NG and HG. g, i Summarised
data showing the arbitrary unit of (g) cytosolic O2
− (ratio of EB/DHE;
NG=6 cells, HG=8 cells) and (i) mitochondrial O2
− (MitoSOX
intensity normalised by NG; NG n=12 cells, HG n=8 cells). Data are
mean ± SEM. *p<0.05 vs NG
Diabetologia (2010) 53:1783–1794 1789(Electronic Supplementary Material [ESM] Fig. 1). This
implies that restoration of mitochondrial morphology might
be a direct effect of the decrease in O2
− concentration by
TEMPOL administration, but one that is not mediated by
the change in fusion–fission-related protein level.
Mitochondrial fragmentation induced by 24 h high-glucose
treatment was restored by TEMPOL treatment in
HCECs HCECs were exposed to NG (5 mmol/l glucose+
20 mmol/l mannitol), HG (25 mmol/l glucose) or
TEMPOL+HG for 24 h and mitochondrial morphological
changes were determined. Figure 6a, b demonstrates that
TEMPOL treatment significantly increased the mitochon-
drial volume that was decreased by high-glucose treatment.
In contrast to the result of hyperglycaemia in vivo, the
effect of 24 h high-glucose levels on mitochondrial
fragmentation ex vivo was not related to a change in
OPA1 protein level. On the other hand, DRP1 was
increased by high glucose and TEMPOL did not have
an effect on DRP1 protein level ex vivo in line with the in
vivo data (Fig. 6c–e). Other fusion–fission-related protein
levels are shown in ESM Fig. 2. These data imply that
increased DRP1 may contribute to excess mitochondrial
fragmentation independent of increased O2
− production
under hyperglycaemic conditions.
High-glucose treatment over 24 h significantly increased
cytosolic and mitochondrial O2
− concentrations (Fig. 6f–i).
To test whether excess O2
− production has a direct effect on
mitochondrial fragmentation, we used two types of O2
−
generator: one for cytosol (10 μmol/l DETA) and another
for mitochondria (100 μmol/l menadione). Cells were
incubated with O2
− generators for 1 h at room temperature
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Fig. 7 O2
− regulates mitochondrial morphology. Cells were incubated
with compounds that generate O2
− in cytosol (10 μmol/l DETA), or in
mitochondria (100 μmol/l menadione) for 1 h at room temperature and
then stained with Mito Tracker Green to visualise mitochondrial
morphology. a Representative images showing mitochondrial mor-
phology in HCECs with or without DETA. Bar=5 μm. b Summarised
data for mitochondrial volume (μm
3) in ECs. Data are mean ± SEM,
n=6 cells in each group.
*p<0.05 vs without DETA (−DETA).
c Western blot showing OPA1, DRP1 and actin protein levels in
HCECs with or without DETA. d Representative images showing
mitochondrial morphology in HCECs with or without menadione.
Scale bar, 5 μm. e Summarised data of mitochondrial volume (μm
3)i n
ECs without menadione (−mena, n=12 cells) and with menadione
(+mena, n=6 cells). Data are mean ± SEM. *p<0.05 vs without
menadione. Excess O2
− generation in cytosol or mitochondria
significantly increased mitochondrial fragmentation without changing
OPA1 and DRP1 protein levels
1790 Diabetologia (2010) 53:1783–1794and then stained with Mito Tracker Green to visualise
mitochondrial morphology. As shown in Fig. 7, overpro-
duction of O2
− in either cytosol or mitochondria caused
significant mitochondrial fragmentation without changing
OPA1 and DRP1 protein levels, suggesting that hyper-
glycaemia ex vivo might lead to mitochondrial fragmenta-
tion by the increase in O2
− production and DRP1 protein
upregulation, but that they might then contribute to
mitochondrial fragmentation separately. Levels of other
fusion–fission-related proteins are shown in ESM Fig. 3.
Drp1–shRNA transfection induced mitochondrial elonga-
tion under high-glucose treatment To test the effect of
DRP1 downregulation on high-glucose-induced mitochon-
drial fission, Drp1–shRNA (1 μg) was transfected in
HCECs by electroporation. Two days after transfection,
cells were treated with high glucose or mannitol for 24 h.
As shown in Fig. 8, decreased level of DRP1 protein led to
increased mitochondrial elongation under high-glucose
treatment, suggesting that high glucose causes, at least in
part, mitochondrial fragmentation by increasing the DRP1
protein level.
Discussion
For the first time, a quantification of mitochondrial
morphological changes in living cells, comparing control
and diabetic cells, was performed. Mitochondria in MCECs
isolated from control mice appear as elongated tubular
structures with many branches. In contrast, MCECs from
diabetic mice have more fragmented mitochondria with
significantly smaller volume than mitochondria in control
MCECs (Fig. 1). The physiological significance of the
continual fusion and fission of mitochondria is still under
debate. A possible function for fusion could be a rescue
mechanism for damaged mitochondria involving exchange
of mtDNA and/or mitochondrial protein [11]. The predom-
inant gene responsible for autosomal-dominant optic
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Fig. 8 Downregulation of DRP1 protein level decreases high-
glucose-treatment-induced mitochondrial fragmentation in HCECs.
Drp1–shRNA (shDrp1) or control–shRNA (shCont) plasmids (1 μg)
were transfected into HCECs by electroporation. Two days after the
transfection, cells were treated with high glucose (25 mmol/l) or
normal glucose (5 mmol/l glucose + 20 mmol/l mannitol) for 24 h.
a Representative images showing mitochondrial morphology in ECs
with control–shRNA in NG (NG w/shCont), with control–shRNA in
HG (HG w/shCont), and with Drp1–shRNA in HG (HG w/shDrp1).
Scale bar, 5 μm. b Summarised data for mitochondrial volume (μm
3).
Data are mean ± SEM, n=8 cells in each group. *p<0.05 vs NG
w/shCont. c Western blot showing DRP1 and actin protein levels on
day 3 after Drp1 or control shRNA transfection. Drp1–shRNA
transfection successfully decreased DRP1 protein concentration
Diabetologia (2010) 53:1783–1794 1791atrophy has been identified as OPA1 [19, 20] and those
patients exhibit significantly lower copy number of
mitochondrial DNA molecules, which may result from
decreased mitochondrial fusion [21]. A recent report
demonstrated that Fis1 transfection in clone 9 cells led to
increased cell apoptosis. A targeted null mutation of either
Mfn1 or Mfn2 results in mid-gestational lethality [23].
Another study shows a naturally occurring neuropathy is
associated with Mfn2 mutation [24]. In addition, MFN2
was identified as a suppressor of obesity [27, 28]a n d
hypertension [25]. Taken together, these data suggest that
increased mitochondrial fission disrupts the normal func-
tion of different kinds of cells and may cause organ failure
and systemic disease. Figure 2 demonstrates that the fusion-
related protein OPA1 level is significantly decreased and
fission-related protein DRP1 is significantly increased in
MCECs from diabetic mice compared with control mice, but
other fusion- or fission-related protein levels do not change
(MFN2 and FIS1) or change in a way which is contrary to
our expectations (MFN1). The decrease in OPA1 and the
increase in DRP1 protein level might be, at least in part, one
of the causes of increased mitochondrial fragmentation in
diabetic MCECs. As the increase in MFN1 protein is
supposed to increase mitochondrial fusion, we hypothesise
that in this cell type MFN1 is not a major player in the
determination of mitochondrial morphology and further
study is required to test this hypothesis.
It has been documented that hyperglycaemia induces
excess ROS production, including O2
−, in many cell types
[31–35, 40–43] and local ROS formation is considered to
be a major contributing factor to endothelial dysfunction,
including endothelial cell apoptosis [42–44], abnormalities
in cell cycling [44] and delayed replication [41]. Our data
demonstrate that MCECs isolated from diabetic mice
exhibit significantly higher production of cytosolic and
mitochondrial O2
− (Fig. 3) and, interestingly, that chronic
reduction of O2
− by TEMPOL administration increased
mitochondrial volume to a level even above that of control
MCECs (Fig. 5a,b) without changing OPA1 and DRP1
protein levels (Fig. 5c–e). This suggests that O2
− concen-
tration might serve as a direct regulator of mitochondrial
morphology. Our ex vivo data also support this hypothesis.
As seen in Fig. 6, HCECs exposed to high glucose for 24 h
show significantly decreased mitochondrial volume, which
is reversed by treatment with the O2
− scavenger TEMPOL.
This high-glucose-treatment-induced mitochondrial frag-
mentation was also decreased by Drp1–shRNA transfec-
tion (Fig. 8), implying that these morphological changes
by 24 h-high-glucose exposure are not mediated by the
fusion-related protein OPA1, but by DRP1 protein upre-
gulation and/or by excess O2
− production in the cytosol
and mitochondria. In addition, exogenous O2
− overpro-
duction by DETA or menadione directly changed the
mitochondrial morphology and increased fragmentation
(Fig. 7). These data suggest that increased O2
− in ECs may
potentially cause mitochondrial fragmentation in the
diabetic heart.
There is increasing evidence to show that ROS can
directly initiate mitochondrial fragmentation in different
cell types [45–48]; the detailed mechanisms are, however,
still unclear. It is known that O2
− can activate protein
kinase C (PKC) in ECs [49, 50], although PKC activation
can also stimulate O2
− generation. It is thus possible that
morphological dynamics in mitochondria could be con-
trolled by PKC activation initiated by O2
−. Our data show
that treatment with 100 nmol/l phorbol 12-myristate
13-acetate (PMA, a PKC activator) significantly decreased
mitochondrial volume (vehicle 0.01% (vol./vol.) DMSO,
0.24±0.01 μm
3;P M A ,0 . 1 5±0 . 0 2μm
3; p<0.05, n=5 each
group). Although these data imply that PKC directly
regulates mitochondrial morphology, it doesn’td e f i n et h e
relationship between PKC and O2
−. It would be necessary
to use a PKC inhibitor to identify whether O2
−-mediated
mitochondrial fission is controlled by PKC activation in
diabetic MCECs.
These data suggest that O2
− overproduction, a decrease
in the fusion-related protein OPA1 and an increase in the
fission-related protein DRP1 in MCECs in diabetic mice
lead to mitochondrial fragmentation, and that treatment
with an O2
− scavenger may help improve mitochondrial
function by decreasing mitochondrial fragmentation.
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